首页> 美国卫生研究院文献>Scientia Pharmaceutica >Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique
【2h】

Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique

机译:固体分散技术改良刺槐豆胶改善阿托伐他汀钙的溶解度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present research was aimed at the enhancement of the dissolution rate of atorvastatin calcium by the solid dispersion technique using modified locust bean gum. Solid dispersions (SD) using modified locust bean gum were prepared by the modified solvent evaporation method. Other mixtures were also prepared by physical mixing, co-grinding, and the kneading method. The locust bean gum was subjected to heat for modification. The prepared solid dispersions and other mixtures were evaluated for equilibrium solubility studies, content uniformity, FTIR, DSC, XRD, in vitro drug release, and in vivo pharmacodynamic studies. The equilibrium solubility was enhanced in the solid dispersions (in a drug:polymer ratio of 1:6) and other mixtures such as the co-grinding mixture (CGM) and kneading mixture (KM). Maximum dissolution rate was observed in the solid dispersion batch SD3 (i.e. 50% within 15 min) with maximum drug release after 2 h (80%) out of all solid dispersions. The co-grinding mixture also exhibited a significant enhancement in the dissolution rate among the other mixtures. FTIR studies revealed the absence of drug-polymer interaction in the solid dispersions. Minor shifts in the endothermic peaks of the DSC thermograms of SD3 and CGM indicated slight changes in drug crystallinity. XRD studies further confirmed the results of DSC and FTIR. Topological changes were observed in SEM images of SD3 and CGM. In vivo pharmacodynamic studies indicated an improved efficacy of the optimized batch SD3 as compared to the pure drug at a dose of 3 mg/kg/day. Modified locust bean gum can be a promising carrier for solubility enhancement of poorly water-soluble drugs. The lower viscosity and wetting ability of MLBG, reduction in particle size, and decreased crystallinity of the drug are responsible for the dissolution enhancement of atorvastatin. The co-grinding mixture can be a good alternative to solid dispersions prepared by modified solvent evaporation due to its ease of preparation and significant improvement in dissolution characteristics.
机译:本研究旨在通过使用改良刺槐豆胶的固体分散技术提高阿托伐他汀钙的溶解速率。通过改良的溶剂蒸发法制备了使用改良的刺槐豆胶的固体分散体(SD)。还通过物理混合,共研磨和捏合方法制备其他混合物。将刺槐豆胶加热以进行改性。评价制备的固体分散体和其他混合物的平衡溶解度研究,含量均匀性,FTIR,DSC,XRD,体外药物释放和体内药效学研究。在固体分散体(药物:聚合物比率为1:6)和其他混合物(例如共研磨混合物(CGM)和捏合混合物(KM))中,平衡溶解度得到了增强。在固体分散体批次SD3中观察到最大溶解速率(即在15分钟内50%),在所有固体分散体中2小时后释放出最大药物(80%)。在其他混合物中,共研磨混合物的溶解速率也显着提高。 FTIR研究表明固体分散体中没有药物-聚合物相互作用。 SD3和CGM的DSC温谱图的吸热峰的微小变化表明药物结晶度略有变化。 XRD研究进一步证实了DSC和FTIR的结果。在SD3和CGM的SEM图像中观察到拓扑变化。体内药效学研究表明,与3 mg / kg / day剂量的纯药物相比,优化批次SD3的功效有所提高。改性刺槐豆胶可以用作水溶性较差的药物的增溶剂。 MLBG的较低粘度和润湿能力,减小的粒径和降低的结晶度是阿托伐他汀溶解增强的原因。共研磨混合物可以很好地替代通过改进的溶剂蒸发法制备的固体分散体,因为它易于制备并且溶解特性显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号